Savings or convenience? Why not both! Buy Digoxin with us!

BTG is offering to take over Protherics in an all-share deal valued at 218.1 million, or about $396.28 million. Protherics independent directors who collectively hold 3.03% of Protherics stock have already agreed to vote in favor of the merger.
The acquisition is expected to be completed by early December. If the agreement g…